Clinical Trial Update: Sitaxsentan Efficacy And Safety Trial With A Randomized Prospective Assessment Of Adding Sildenafil (SR-PAAS) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating sitaxsentan for pulmonary arterial hypertension with an assessment of adding sildenafil; the study was terminated and results were post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension
• Pulmonary Hypertension

Drugs mentioned

• SILDENAFIL (SILDENAFIL)
• Sitaxsentan (sitaxsentan)

Snippet

Sponsor: Pfizer | Conditions: Pulmonary Arterial Hypertension, Pulmonary Hypertension | Phase 3 | Status: TERMINATED | Results posted: 2012-03-01